l12: part 2 Flashcards

1
Q

what is the explanation for developing autoimmune diseases after infections

A

molecular mimicry, in which epitopes relevant to the pathogen are shared with host antigens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Describe the aeitiology of type 1 diabetes

A

Lack of insulin impairs cellular update of glucose, leading to polyuria, polydypsia, polyphagia and weight loss

Onset at any age, but typically childhood

Disease prevalence around 0.8%; rising by around 5% per anum

Treatment by injection of insulin and diet

Important to differentiate from:
-Monogenic diabetes - can present with a similar phenotype but requires different management

-Type II diabetes mellitus = older onset, insulin secretion, ketoacidosis less likely and insulin not necessarily required

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is the evidence for autoimmune disease in t1 diabetes

A
  • Islet cell antibodies detectable for months to years before the onset of clinical disease
  • HLA associations
  • Mouse model
  • Early pancreatic biopsy shows infiltration with CD4/ 8 T cells
  • Note that although antibodies present, they do not appear to be directly relevant to destruction of the pancreas

-By the time patient has established
diabetes, generally no active inflammation
in pancreatic biopsy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what % of the pancreas has to be lost (and what other factor) for overt diabetes to be developed

A

90%

decrease in beta cell mass

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

describe the process of molecular mimicry

A
  • Viral infection: presentation of viral peptides to a CD4 T cell via MHC 2, causing T cell activation
  • The viral peptides happen to be similar to a host-derived peptide; the T cell would normally recognise these peptides, but would not react to them
  • The activated T cell now reacts strongly to the self-peptide and initiates inflammation
  • The process depends on having the correct MHC molecules to present this critical epitope that is common to both virus and host (inherited)
  • Also depends on having the correct T cell to recognise it (mainly bad luck)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

give some examples of molecular mimicry

A

Autoimmune haemolysis after Mycoplasma pneumoniae:

  • Mycoplasma antigen has homology to ‘I’ antigen on red blood cells
  • IgM antibody to mycoplasma may cause transient haemolysis

Rheumatic fever: inflammatory disease occurring after streptococcal infection affecting heart, joints, skin and brain

-Anti-streptococcal antibodies believed to cross-react with connective tissue

-Even for these ‘best examples’ the target antigens are not well-defined; for other diseases the paradigm remains rather theoretical
the paradigm remains rather theoretical

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what are the genetics behind type 1 diabetes

A

HLA class II alleles are the major defined genetic risk factor

  • DR3 or DR4 relative risk is 6
  • DR3 and DR4 relative risk is 15
  • Rather like coeliac disease, believed that these molecules are required to present relevant islet cell antigens to CD4 T cells
  • Autoimmune response may occur if appropriate T cell receptors are present, together with other genetic and environmental co-factors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what are the precipitating events to type 1 diabetes

A

Autoantibodies to islet cell antigens present for months-years before onset of clinical disease

Coxsackie virus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is the evidence for coxsackie virus triggering type 1 diabetes

A
  • Stronger immune response to virus in cases compared to controls
  • Viral infection can cause pancreatitis in mice and humans, and precipitate autoimmune diabetes in mouse models
  • Protein 2C from Coxsackie virus has homology with islet cell antigen glutamic acid decarboxylase (GAD) (?molecular mimicry mechanism)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

summarise the development of AID in 4 steps

A

MHC background: Critical for some diseases in determining which peptides can be presented

T cell receptor repertoire: critical in determining whether the peptide-MHC complex can be recognised. Note: the gene segments are inherited, but the receptors are produced randomly and will differ even in identical twins

Infection: may influence the activation of T cells and B cells that are potentially auto reactive

Likely to be myriad other genetic and environmental factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what are the cases in which antibodies have diagnostic value

(Autoimmune serology for diagnosis)

A

In some cases the antibodies are pathogenic

In others, they are simply a bystander effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what are the 3 methods that you can do for Autoimmune serology for diagnosis

A
  • Indirect immunofluorescence
  • Solid-phase immunoassay
  • Direct immunofluorescence
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what is indirect immunofluorescence

A
  • detecting antibodies in the blood, serum or other bodily fluids
  • makes use of 2 antibodies while the primary antibody I unconjugated the second is Fluorophore-conjugated antibody is used for the detection of the source of the problem
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

describe the indirect immunofluorescence method

A

1- incubation )

patient serum containing (or not) relevant antibodies

It’s added to a glass slide with tissue of interest

2- detection)
Add detection antibody labelled with fluorescent marker

3-read) Look for fluorescence under microscope

sd: (Detection antibody sticks onto fc region
)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what is direct immunofluorescence

A
  • it makes use of a single antibody to target the point of interest. The primary antibody is directly coupled with to a fluorophore
  • looking for antibodies in the tissue biopsy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what does indirect immunofluorescence positive staining detect in the pancreas of someone with type 1 diabetes

A
  • staining of islets demonstrate the presence of islet cell autoantibodies
17
Q

what is Indirect immunofluorescence of the pancreas being replaced by

A

immunoassays for specific islet cell antigens (GAD, IA2, insulin

18
Q

why is it important to identify type 1 DM

A

Risk of ketoacidosis

Requires insulin

Monongenic diabetes and type 2 diabetes require a different approach

19
Q

give a quick overview of the Detecting antibodies in blood by immunoassay (ELISA)

A
  • antigen coated well
  • specific antibody binds to antigen
  • Enzyme linked antibody binds to specific antibody
  • substrate is added and converted by enzyme into coloured product; the rate of colour formation is proportional to the amount of specific antibody
20
Q

give an alternate newer method of ELISA

A

Particle bead suspension

Magnetic particle- sample- tracer- triggers light emission

21
Q

Principles of the experiment (ELISA)

1

A

In the next step, your patient samples are added to the wells

The samples are incubated, to allow time for tTG antibody in the samples to react with the tTG antibody

Excess antibody is washed off

If there was tTG antibody in the sample, it will now be captured by the immobilised tTG antigen – however, this reaction is of course invisible at this stage

22
Q

Principles of the experiment (ELISA)2

A

A secondary antibody is added

The secondary antibody is an anti-IgA antibody, which binds to IgA Fc regions

It’s covalently linked to an enzyme such as horse radish peroxidase, indicated as a red circle on the figure below

Excess secondary antibody is washed away

23
Q

Principles of the experiment (ELISA)3

A

A substrate is now added

The substrate reacts with the horse radish peroxidase that is bound to the secondary antibody, which in turn is bound to antibody tTG antibody that was present in the patient sample

This produces a colour change, which you will be able to see with the naked eye in strong reactions

The amount of colour change can be measured using a photocell

24
Q

Principles of the experiment (ELISA)4

A

In parallel with all of this, you will be setting up a calibration curve

This involves setting up wells containing known concentrations of tTG antibody

The photocell readings from each well are used to create a standard curve, to which you can relate the values from your patient samples

You will also run positive and negative controls, to show that the assay has worked correctly

Note that everything is run in triplicate, to improve precision

25
Q

how is a A range of tTG concentrations are produced from solution A, which is neat rTG solution
produced

A

This is done by SERIAL DILUTION, taking 500 microliters of A and adding to 500 microliters of buffer in B,
Then repeating through tubes C to H

26
Q

Note: slide 56

A

Capture antigen: human tTG

Antibody: antibody tTG

Detection Ab:
polyclonal goat anti human IgA-peroxidase

Substrate:
Tetramethylbenzidine (TMB)

27
Q

describe direct immunofluorescence

A

1- Preparing tissue biopsy/slide)

Take a biopsy of affected tissue eg skin, kidney; if damage mediated by antibody, antibody will already be stuck to its antigen in the tissue

2-detection)
Add detection antibody labelled with fluorescent marker

3-read)
Look for fluorescence under microscope

28
Q

Aetiology of Bullous skin disease: pemphigoid

A

Thick-walled bullae, rarely on mucus membranes

Fulfils criteria for antibody-mediated disease

Target is antigen at dermo-epidermal junction

Linear deposition of antibody, which activates complement producing skin dehiscence and tense blister

29
Q

how is Aetiology of Bullous skin disease: pemphigoid detected

A

Direct-immunofluorescence

30
Q

aetiology of Bullous skin disease: pemphigus

A
  • Thin-walled bullae on skin and mucus membranes, rupture easily
  • Fulfils critiera for antibody-mediated disease
  • Target is the intercellular cement protein desmoglein 3 in superficial skin layers
31
Q

how is coeliac disease diagnosed

A

Indirect immunofluorescence

32
Q

describe the 3 methods in which coeliac disease diagnosed

A

1) Antibodies binding to the endomysium of smooth muscle fibres found to have a strong disease association with coeliac disease in the 1990s.
2) Subsequently target antigen found to be tissue tranglutaminase (tTG), which is now expressed in recombinant systems to provide antigen for modern immunoassays
3) HLA typing also increasing utilised – absence of HLA DQ-2/ 8 makes coeliac disease very unlikely (ie high negative predictive value)

33
Q

how is vitamin B12 absorbed

A

Vitamin B12 absorbed in terminal ileum

Absorption requires a co-factor called INTRINSIC FACTOR which is secreted by the gastric parietal cells

34
Q

what occurs in pernicious anaemia

A

Pernicious anaemia describes autoimmune destruction of the gastric parietal cells

Loss of intrinsic factor abrogates B12 absorption

Liver stores around 2 years supply of B12

Once depleted, multiple possible manifestations:

  • Anaemia
  • Neurological
  • Subfertility
35
Q

how is pernicious anaemia diagnoses

A

Gastric parietal cell antibodies demonstrated by indirect immunofluorescence with rodent stomach

36
Q

give some examples of how some AIDs are treated for

A
  • Thyroxine for under reactive thyroid
  • Carbimazole, surgery or drugs for thyrotoxicosis
  • Insulin for diabetes
  • B12 for pernicious anaemia

these are treating the immunology

37
Q

give the examples of the treatments for , in some AID, particularly non organ-specific, treatment of the immune system is the best option

A

Used particularly for ‘multi-system’ autoimmune diseases

Systemic corticosteroids

Small molecule immunosuppressive drugs (eg methotrexate, azathioprine, ciclosporin)

High-dose intravenous immunoglobulin (mechanism poorly understood)

Increasing interest in ‘biologics’ – see seminar

38
Q

describe plasmapheresis

A

Plasmapharesis removes antibodies from the bloodstream therefore may be useful in antibody-mediated diseases

separates plasma containing clotting factors and complement into separate bag via spinning centrifuge bowl

left with serum

39
Q

give some examples of systemic autoimmune diseases

A

Systemic lupus erythematosis

Rheumatoid arthritis